2H62

Crystal structure of a ternary ligand-receptor complex of BMP-2


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free: 0.225 
  • R-Value Work: 0.216 
  • R-Value Observed: 0.216 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.

Weber, D.Kotzsch, A.Nickel, J.Harth, S.Seher, A.Mueller, U.Sebald, W.Mueller, T.D.

(2007) BMC Struct Biol 7: 6-6

  • DOI: 10.1186/1472-6807-7-6
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • Bone morphogenetic proteins (BMPs) are key regulators in the embryonic development and postnatal tissue homeostasis in all animals. Loss of function or dysregulation of BMPs results in severe diseases or even lethality. Like transforming growth facto ...

    Bone morphogenetic proteins (BMPs) are key regulators in the embryonic development and postnatal tissue homeostasis in all animals. Loss of function or dysregulation of BMPs results in severe diseases or even lethality. Like transforming growth factors beta (TGF-betas), activins, growth and differentiation factors (GDFs) and other members of the TGF-beta superfamily, BMPs signal by assembling two types of serine/threonine-kinase receptor chains to form a hetero-oligomeric ligand-receptor complex. BMP ligand receptor interaction is highly promiscuous, i.e. BMPs bind more than one receptor of each subtype, and a receptor bind various ligands. The activin type II receptors are of particular interest, since they bind a large number of diverse ligands. In addition they act as high-affinity receptors for activins but are also low-affinity receptors for BMPs. ActR-II and ActR-IIB therefore represent an interesting example how affinity and specificity might be generated in a promiscuous background.


    Organizational Affiliation

    Lehrstuhl für Physiologische Chemie II, Theodor-Boveri Institut für Biowissenschaften (Biozentrum) der Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany. dweber@biozentrum.uni-wuerzburg.de



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Bone morphogenetic protein 2
A, B
114Homo sapiensMutation(s): 0 
Gene Names: BMP2BMP2A
Find proteins for P12643 (Homo sapiens)
Go to UniProtKB:  P12643
NIH Common Fund Data Resources
PHAROS  P12643

Find similar proteins by: Sequence  |  Structure

Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Bone morphogenetic protein receptor type IA
C
129Homo sapiensMutation(s): 0 
Gene Names: BMPR1AACVRLK3ALK3
EC: 2.7.11.30
Find proteins for P36894 (Homo sapiens)
Go to UniProtKB:  P36894
NIH Common Fund Data Resources
PHAROS  P36894

Find similar proteins by: Sequence  |  Structure

Entity ID: 3
MoleculeChainsSequence LengthOrganismDetails
Acvr2b protein
D
98Homo sapiensMutation(s): 0 
Gene Names: BMPR1AACVRLK3ALK3ACVR2B
EC: 2.7.11.30
Find proteins for Q13705 (Homo sapiens)
Go to UniProtKB:  Q13705
NIH Common Fund Data Resources
PHAROS  Q13705
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free: 0.225 
  • R-Value Work: 0.216 
  • R-Value Observed: 0.216 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 64.131α = 90
b = 65.368β = 90
c = 114.067γ = 90
Software Package:
Software NamePurpose
CrystalCleardata collection
d*TREKdata reduction
CNSrefinement
CrystalCleardata reduction
d*TREKdata scaling
CNSphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2006-05-30 
  • Released Date: 2007-04-10 
  • Deposition Author(s): Mueller, T.D.

Revision History 

  • Version 1.0: 2007-04-10
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance